Morgan Stanley’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Sell
272,473
-46,918
-15% -$255K ﹤0.01% 4893
2025
Q1
$1.11M Buy
319,391
+157,343
+97% +$546K ﹤0.01% 4954
2024
Q4
$1.67M Sell
162,048
-493
-0.3% -$5.07K ﹤0.01% 4828
2024
Q3
$2.2M Buy
162,541
+34,849
+27% +$472K ﹤0.01% 4579
2024
Q2
$1.66M Sell
127,692
-2,447
-2% -$31.8K ﹤0.01% 4675
2024
Q1
$1.23M Sell
130,139
-254,763
-66% -$2.4M ﹤0.01% 4855
2023
Q4
$4.22M Buy
384,902
+278,377
+261% +$3.05M ﹤0.01% 4479
2023
Q3
$681K Sell
106,525
-26,593
-20% -$170K ﹤0.01% 5009
2023
Q2
$640K Buy
133,118
+45,927
+53% +$221K ﹤0.01% 5097
2023
Q1
$359K Buy
87,191
+40,656
+87% +$168K ﹤0.01% 5443
2022
Q4
$200K Buy
46,535
+39,375
+550% +$169K ﹤0.01% 5672
2022
Q3
$136K Buy
+7,160
New +$136K ﹤0.01% 5922